We found that the expression of TIGIT, which inhibits NK cell function, is increased on CD56+ and CD56dim NK cells in DN-CML PB compared with those in healthy individuals (HIs), and it is restored to normal in patients who achieve MR. The gene discussed is NCAM1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.